← All stories
Events

Integrating Pharma & Social Care Summit: Thank You and Takeaways

Speakers and attendees of the Gryt Health and Findhelp Integrating Pharma & Social Care Summit

Gryt Health and Findhelp extend our gratitude to the leaders who used unflinching conversation to inspire outcomes-focused action. Your expertise and authenticity made the event more impactful than we could have imagined.

When we were designing this Summit, our shared goal was laser-focused. How do we address the critical industry challenge to seamlessly integrate social care into both clinical development and commercial operations?

As pharmaceutical, life sciences, and community health leaders, we know first-hand that colleagues get reassigned, budgets shift, and regulatory environments change. These real and tactical dynamics challenge the continuity of addressing #SocialDeterminantsofHealth in drug development.

Throughout the Summit, cross-stakeholder leaders from pharma, patient advocacy, healthcare, and community organizations explored a critical mission: ensuring that scientific breakthroughs translate into equitable, accessible care. By embedding social care directly into clinical development and commercial strategies, we can build a more connected, responsive, and human-centered healthcare ecosystem.

What unfolded wasn’t just a day of panels and workshops. It was a vivid reminder that behind every clinical trial protocol, dataset, and commercial workflow is a human story. Thank you for the work you do every day 💛

Thank you to our speakers

Elevating the Patient Voice

Beth Brooks from Sanofi explored how well-intentioned organizational missions often get refracted through regulatory, data quality, and feasibility lenses, creating unintended burdens for patients, such as requiring patients with mobility challenges to transport heavy medical coolers. Beth called for treating advocacy as a deliberate method to address systemic barriers like transportation, time off work, housing, and institutional distrust. To help teams translate this into practice, attendees were encouraged to adopt a four-step framework in future meetings: name the specific person, trace their burdens, confirm assumptions, and close the loop whenever plans change.

Integrating Patient Voice, Biopharma Leadership, and Community Trust

Jael Johnson, Dr. Chantell Frazier, and Monique Gore-Massy led a candid discussion on moving from transactional patient outreach to authentic community partnership. Jael highlighted the distinction between merely recruiting patients versus supporting their participation in clinical research by addressing logistics, caregiving duties, and cultural factors early in study design. Chantell highlighted patient experience as a strategic asset, noting that storytelling aligns personal motivation with organizational goals and cautioning that high referral metrics (such as a 68% referral rate) do not prove true impact without tracking downstream clinical outcomes. By sharing her personal journey living with lupus, Monique reminded attendees that “the patient has a bridge of concerns before they get to you,” urging companies to move beyond safe allyship to true accompliceship by embedding lived expertise across every department.

Co-Designing Solutions: A Collaborative Workshop

We were honored to have Sheila Thorne lead this co-creation exercise to address a critical industry challenge: how to sustain social care in both clinical development and commercial operations. It called on the expertise and #LivedExperiences of everyone in the room.

Participants transitioned from principles into action within small-group working sessions focused on overcoming internal risk aversion, cultural silos, and resource constraints. Teams evaluated specific patient journey barriers and drafted actionable impact statements demonstrating how early SDoH integration strengthens equitable care delivery and clinical trial recruitment.

Breaking Barriers in Health Equity

The Summit concluded with an executive panel focused on scaling social care integration from isolated pilots into durable, enterprise-wide standards. Briana Edouard and Dr. Kamala Maddali discussed deploying automated workflows, real-world data platforms, and AI navigation guides alongside community directories to proactively resolve food, financial, and transportation barriers. To protect initiatives from budget pressures, they urged organizations to give ongoing programs permanent names, secure broad executive sponsorship, and build public-private consortia across biopharma, technology providers, and healthcare systems.